The following warnings occurred:
Warning [2] Undefined variable $unreadreports - Line: 32 - File: global.php(961) : eval()'d code PHP 8.1.27 (Linux)
File Line Function
/inc/class_error.php 153 errorHandler->error
/global.php(961) : eval()'d code 32 errorHandler->error_callback
/global.php 961 eval
/showthread.php 28 require_once




Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Rogan & Malone
#1
mRNA inventor Dr. Robert Malone gave a fascinating interview to Joe Rogan which aired on New Year's Eve.

If you've got three hours to spare, we recommend you watch the entire thing:



Malone, an expert in mRNA vaccine technologies who trained at UC Davis, UCSD and the Salk Institute, was suspended by Twitter with no explanation on Thursday. It appears he's preparing to sue, as Alex Berenson is currently doing.




The suspension came after Malone was vilified by a hit piece in The Atlantic which was funded by Facebook and Johnson & Johnson.

"Three days before this thing came out, the journalist - he previously publishes on 'woke' issues on the topic of higher education. He's clearly hired. And they explicitly say the article was funded by the Robert Boyd Johnson foundation and the Zuckerberg-Chan initiative.

...

He was totally obsessed. 'Robert, why are you saying these things? You must have some financial incentive. There must be some reason you're doing this' - and I told him repeatedly, 'because it's the right thing to do.'

I think I'm the only one who has been involved deeply in the development of this tech, that doesn't have a financial stake in it. For me, the reason is, because what's happening is not right. It's destroying my profession. It's destroying the practice of medicine worldwide ... I'm a vaccinologist. I spent 30 years developing vaccines. A stupid amount of education learning how to do it, and what the rules are. And for me, I'm personally offended watching my discipline get destroyed for no good reason at all except, apparently, financial incentives, and - I dunno - political ass-covering?" -Robert Malone


"Our government is out of control on this," Malone continues. "And they are lawless. They completely disregard bioethics. They completely disregard the federal common-rule. They have broken all the rules that I know of, that I've been trained for years and years and years. These mandates of an experimental vaccines are explicitly illegal. They are explicitly inconsistent with the Nuremberg code. They are explicitly inconsistent with the Belmont report. They are flat out illegal, and they don't care."


Malone then explained to Rogan how the Uttar Pradesh province in India crushed Covid with early treatment that included ivermectin, however he claims that the Biden administration met with Modi and a 'decision was made not to disclose the contents of the treatment.'


They then went deeper into the topic of ivermectin and early interventions in general. According to Malone, "There are good modeling studies, that show a half a million excess deaths have happened in the US, through the intentional blockade of early COVID treatment by the US Government."



Malone and Rogan then got into some heavy science behind Covid - with Malone explaining how people with natural Covid immunity are at higher risk of adverse events from the vaccine.

"There is a number of things here that are not supported by the science."


They then discussed the case of a 14-year-old girl who was injured by the vaccine, yet the incident was reported as a stomach ache.

"This young woman who was listed as having a stomach ache, when in fact what she had was a seizure. And she's now wheelchair-bound with a nasal-gastric tube. One of 1,000 subjects."


Towards the end of the interview, Malone gets even deeper - suggesting that people are living through a mass formation psychosis - drawing parallels to 1920s and 1930s Germany, where "they had a highly intelligent, highly educated population, and they went barking mad."


And Twitter doesn't think Malone's voice deserves to be heard.
“If you want to know who rules over you, just look for who you are not allowed to criticize.”

― Voltaire
Reply
#2
Malone didn’t invent mRNA vaccine
Reply
#3
Dr. Robert Malone invented the mRNA technology.
“If you want to know who rules over you, just look for who you are not allowed to criticize.”

― Voltaire
Reply
#4
He did not. Only the small mind/time clones say that.
Reply
#5
Who invented it?
“If you want to know who rules over you, just look for who you are not allowed to criticize.”

― Voltaire
Reply
#6
It was developed over decades. But Drew Weissman and Katalin Karikó seem to be the biggest players
Reply
#7
Patents by Inventor Robert W. Malone
Robert W. Malone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

Compounds and methods for enhancing delivery of free polynucleotide
Publication number: 20040009947
Abstract: The discovery of simple, nontoxic, and pharmaceutically defined methods for genetic modification of cells and tissues would enable development of a variety of molecular medicines. “Free”, ‘direct’, or ‘naked’ polynucleotide administration is a simple, apparently safe, and pharmaceutically defined polynucleotide delivery method. Murine, macaque, and clinical human experiments have demonstrated transfection of various tissues, such as respiratory tissues, after direct application of ‘free’ polynucleotide. However, direct DNA transfection is relatively inefficient in comparison to many transduction systems. The invention herein is directed to transfection enhancing agents which augment the transfection activity of ‘free’ polynucleotide, thereby facilitating the development of simple and safe alternatives to tissue transfection, more particularly respiratory tissue transfection.
Type: Application
Filed: May 27, 2003
Publication date: January 15, 2004
Inventors: Robert W. Malone, Jill G. Malone
DNA vaccines for eliciting a mucosal immune response
Patent number: 6110898
Abstract: The invention consists of a method for inducing production of a mucosal immune response in a host by administration of an antigen-encoding polynucleotide preparation, comprising DNA or RNA encoding an antigenic epitope to a mucosal inductor site in the mucosal tissue of the host. Naked DNA may be administered directly to mucosa, for instance in saline drops, or in a recombinant gene expression vector. Preferably, the recombinant gene expression vectors are not capable of replication or dessimination. The invention also includes the use of live viral vaccines wherein the viruses include immunostimulatory polynucleotides of the invention. According to a preferred method of the invention, a target protein antigen is administered through its expression by a recombinant gene expression vector.
Type: Grant
Filed: May 23, 1997
Date of Patent: August 29, 2000
Assignee: University of Maryland, Baltimore
Inventors: Robert W. Malone, Jill G. Malone
Formulations and methods for generating active cytofectin: polynucleotide transfection complexes
Patent number: 5925623
Abstract: In the generation of cytofectin:polynucleotide complexes for transfection of cells, formulations, counterions, and reaction conditions for maximizing the transfection include using a cationic amine compound that has the general structure: ##STR1## wherein R.sub.4 and R.sub.5 are a pair of same or different lipoyl moieties selected from a group consisting of an alkyl, alkenyl, alkynyl, alkanoyl, alkenoyl, or alkynoyl groups and for R.sub.1, R.sub.2, and R.sub.3 at least two are hydroxylated, ether containing, or acyloxy containing alkyl, alkenyl, or alkynyl groups or at least one amine bonded halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group or a mixture of at least one halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group and at least one hydroxylated, ether containing, or acyloxy containing alkyl, alkenyl, or alkynyl group, and X.sup.- is an oxyanion or halide counterion.
Type: Grant
Filed: July 15, 1996
Date of Patent: July 20, 1999
Assignee: The Regents of the University of California
Inventors: Michael H. Nantz, Michael J. Bennett, Rajiv P. Balasubramaniam, Alfred M. Aberle, Robert W. Malone
Cationic transport reagents
Patent number: 5892071
Abstract: For use in transporting biologically active species into and through membrane barriers, a symmetrical cationic diamine compound having the general structure ##STR1## wherein m=1-10; R.sub.1 is a hydrogen, an alkyl group, an alkenyl group, a hydroxylated alkyl or alkenyl group, or an ether containing alkyl or alkenyl group; R.sub.2 is an alkyl group, an alkenyl group, or an alkyl or alkenyl containing acyl group; R.sub.3 is a hydrogen, an alkyl group, an alkenyl group, a hydroxylated alkyl or alkenyl group, or an ether containing alkyl or alkenyl group; R.sub.4 is a hydrogen, an alkyl group, an alkenyl group, a hydroxylated alkyl or alkenyl group, or an ether containing alkyl or alkenyl group; and X.sup.- is an anion.
Type: Grant
Filed: September 15, 1995
Date of Patent: April 6, 1999
Assignee: The Reagents of The University of California
Inventors: Michael H. Nantz, Michael J. Bennett, Robert W. Malone
Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes
Patent number: 5824812
Abstract: Amine containing compounds and their use in the generation of cytofectin:polynucleotide complexes for transfection of cells, formulations, counterions, and reaction conditions for maximizing the transfection include using cationic amine compounds that have the general structure: ##STR1## wherein R.sub.4 and R.sub.5 are a pair of same or different lipoyl moieties selected from a group consisting of an alkyl, alkenyl, alkynyl, alkanoyl, alkenoyl, or alkynoyl groups and for R.sub.1, R.sub.2, and R.sub.3 at least two are hydroxylated, ether containing, or acyloxy containing alkyl, alkenyl, or alkynyl groups or at least one amine bonded halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group or a mixture of at least one halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group and at least one hydroxylated, ether containing, or acyloxy containing alkyl, alkenyl, or alkynyl group, and X.sup.
Type: Grant
Filed: September 17, 1996
Date of Patent: October 20, 1998
Assignee: The Regents of the University of California
Inventors: Michael H. Nantz, Michael J. Bennett, Rajiv P. Balasubramaniam, Alfred M. Aberle, Robert W. Malone
Cationic transport reagents
Patent number: 5744625
Abstract: For use transporting biologically active species into and through membrane barriers, a symmetrical cationic diamine compound having the general structure ##STR1##
Type: Grant
Filed: May 16, 1996
Date of Patent: April 28, 1998
Assignee: The Reagents of the University of California
Inventors: Michael H. Nantz, Michael J. Bennett, Robert W. Malone
Induction of a protective immune response in a mammal by injecting a DNA sequence
Patent number: 5589466
Abstract: A method for delivering an isolated polynucleotide such as DNA or RNA, to the interior of a cell in a mammal comprising the injection of an isolated polynucleotide into a muscle of the mammal where the polynucleotide is taken up by the cells of the muscle and exerts a therapeutic effect on the mammal. The method can be used to deliver a therapeutic polypeptide to the cells of the mammal, to provide an immune response upon in vivo translation of the polynucleotide, to deliver antisense polynucleotides, to deliver receptors to the cells of the mammal or to provide transitory gene therapy.
Type: Grant
Filed: January 26, 1995
Date of Patent: December 31, 1996
Assignees: Vical Incorporated, Wisconsin Alumni Research Foundation
Inventors: Philip L. Felgner, Jon A. Wolff, Gary H. Rhodes, Robert W. Malone, Dennis A. Carson
Delivery of exogenous DNA sequences in a mammal
Patent number: 5580859
Abstract: Polynucleotide sequences, comprising DNA and RNA molecules can be directly administered, for example by injection, to tissues, such as muscle, and expressed as a protein, polypeptide or polypeptide. The polynucleotides can be contained within liposomes or the polynucleotides can free from association with transfection-facilitating proteins, viral particles, liposomal formulations, charged lipids and calcium phosphate precipitating agents.
Type: Grant
Filed: March 18, 1994
Date of Patent: December 3, 1996
Assignees: VICAL Incorporated, Wisconsin Alumni Research Foundation
Inventors: Philip L. Felgner, Jon A. Wolff, Gary H. Rhodes, Robert W. Malone, Dennis A. Carson
Cationic transport reagents
Patent number: 5527928
Abstract: For use in transporting biologically active species into and through membrane barriers, a symmetrical cationic diamine compound having the general structure ##STR1##
Type: Grant
Filed: September 30, 1994
Date of Patent: June 18, 1996
Inventors: Michael H. Nantz, Michael J. Bennett, Robert W. Malone
“If you want to know who rules over you, just look for who you are not allowed to criticize.”

― Voltaire
Reply
#8
https://www.logically.ai/factchecks/library/3aa2eefd
Reply
#9
Like all ankle-biters, they are wrong.

And as usual you don't dispute the content - because you can't.
“If you want to know who rules over you, just look for who you are not allowed to criticize.”

― Voltaire
Reply
#10
(01-02-2022, 12:58 PM)k.d. Wrote: Like all ankle-biters, they are wrong.

And as usual you don't dispute the content - because you can't.

Consider it disputed by um everybody but Malone and the clones
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)